These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10703328)

  • 1. Fluorouracil.
    Hoyer KA
    Clin J Oncol Nurs; 1999 Oct; 3(4):191-2. PubMed ID: 10703328
    [No Abstract]   [Full Text] [Related]  

  • 2. Methotrexate.
    Held-Warmkessel J
    Clin J Oncol Nurs; 2000; 4(4):187-8. PubMed ID: 11261104
    [No Abstract]   [Full Text] [Related]  

  • 3. [Factors of the therapeutic effectiveness of 5-fluorouracil].
    Manziuk LV; Donenko FV; Sitdikova SM; Moroz LV
    Vopr Onkol; 1996; 42(2):31-6. PubMed ID: 8815630
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of 5-fluorouracil in digestive cancer].
    Setiz JF; Perrier H; Giovannini M; Thill L
    Gastroenterol Clin Biol; 1996; 20(5 Pt 2):B80-88. PubMed ID: 8761126
    [No Abstract]   [Full Text] [Related]  

  • 5. From 5 fluorouracil to the new oral fluoropyrimidines: a brief overview of four decades of clinical investigations.
    Sulkes A
    Isr Med Assoc J; 2001 Apr; 3(4):278-81. PubMed ID: 11344842
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of action of fluoropyrimidines: relevance to the new developments in colorectal cancer chemotherapy.
    Sobrero A; Guglielmi A; Grossi F; Puglisi F; Aschele C
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):72-7. PubMed ID: 11049035
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of 5-Fluorouracil derivatives as anticancer agents.
    Pan X; Wang C; Wang F; Li P; Hu Z; Shan Y; Zhang J
    Curr Med Chem; 2011; 18(29):4538-56. PubMed ID: 21864282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [5-fluorouracil and dihydropyrimidine dehydrogenase].
    Kubota T
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):433-9. PubMed ID: 11329775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid and inexpensive method for anticipating severe toxicity to fluorouracil and fluorouracil-based chemotherapy.
    Ciccolini J; Mercier C; Evrard A; Dahan L; Boyer JC; Duffaud F; Richard K; Blanquicett C; Milano G; Blesius A; Durand A; Seitz JF; Favre R; Lacarelle B
    Ther Drug Monit; 2006 Oct; 28(5):678-85. PubMed ID: 17038885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of action of topical 5-fluorouracil: review and implications for the treatment of dermatological disorders.
    Ceilley RI
    J Dermatolog Treat; 2012 Apr; 23(2):83-9. PubMed ID: 21034289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction. Beyond 5-fluorouracil.
    Pazdur R
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):15-6. PubMed ID: 10442352
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction between warfarin and 5-fluorouracil, not between warfarin and levamisole.
    Brown MC
    Clin Pharmacol Ther; 1998 Aug; 64(2):233. PubMed ID: 9728904
    [No Abstract]   [Full Text] [Related]  

  • 13. Flexible Bayesian methods for cancer phase I clinical trials. Dose escalation with overdose control.
    Tighiouart M; Rogatko A; Babb JS
    Stat Med; 2005 Jul; 24(14):2183-96. PubMed ID: 15909291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited sampling model for the analysis of 5-fluorouracil pharmacokinetics in adjuvant chemotherapy for colorectal cancer.
    Di Paolo A; Danesi R; Vannozzi F; Falcone A; Mini E; Cionini L; Ibrahim T; Amadori D; Del Tacca M
    Clin Pharmacol Ther; 2002 Dec; 72(6):627-37. PubMed ID: 12496744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimetabolites.
    Chu E; Grem JL; Johnston PG; Politi PM; Chabner BA; Allegra CJ
    Cancer Chemother Biol Response Modif; 1992; 13():1-30. PubMed ID: 1389906
    [No Abstract]   [Full Text] [Related]  

  • 16. Developing a patient pathway to deliver a new oral chemotherapy.
    Deery P; Faithfull S
    Prof Nurse; 2003 Oct; 19(2):102-6. PubMed ID: 14593785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin-5-FU interactions.
    Giunta G
    Ann Oncol; 2006 Jan; 17(1):176. PubMed ID: 16126735
    [No Abstract]   [Full Text] [Related]  

  • 18. [5-fluorouracil: metabolism and current indications in digestive cancer treatment].
    Aparicio T; Ducreux M; Chaussade S
    Gastroenterol Clin Biol; 2002 Jan; 26(1):38-47. PubMed ID: 11938038
    [No Abstract]   [Full Text] [Related]  

  • 19. The clinical conundrum of managing 5-fluorouracil-induced vasospasm in colorectal carcinoma.
    Nohria A
    Cancer; 2019 Dec; 125(24):4346-4349. PubMed ID: 31544232
    [No Abstract]   [Full Text] [Related]  

  • 20. Can topical 5-fluorouracil be used as a viable treatment option for oral premalignant lesions and tumors?
    Routray S; Dikhit PS; Rajani BC; Khan MM
    Oral Oncol; 2019 Apr; 91():128. PubMed ID: 30777597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.